Terminated PHASE2/PHASE3 INTERVENTIONAL NCT00151307

Effects of Cerebral Oxygen Saturation on Neuropsychological Outcomes

The Effects of Monitoring and Maintaining Cerebral Oxygen Saturation on Neuropsychological Outcomes in Patients Undergoing Cardiac Surgery

Sponsor: New York Presbyterian Hospital

Conditions Cardiovascular Diseases Postoperative Complications

Interventions INVOS cerebral oximeter

Updated 5 times since 2017 Last updated: Jun 5, 2008 Started: Feb 28, 2001 Completion: Apr 30, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Could not recruit any more people.

Other Cardiovascular Diseases trials with similar outcome

Browse all Cardiovascular Diseases trials

Listed as NCT00151307, this PHASE2/PHASE3 trial focuses on Cardiovascular Diseases and Postoperative Complications and remains terminated or withdrawn. Sponsored by New York Presbyterian Hospital, it has been updated 5 times since 2001, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE2_PHASE3
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE2_PHASE3

First recorded

Feb 2001

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

New York Presbyterian Hospital
Weill Medical College of Cornell University

Data source: Weill Medical College of Cornell University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States